LifeStance Health Group, Inc. Proceeds from Long-Term Debt Issued
LifeStance Health Group, Inc. (LFST) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-02-25
- LifeStance Health Group, Inc. proceeds from issuance of long-term debt for the quarter ending 2024-12-31 was $287.81M, a 778.73% increase year-over-year.
- LifeStance Health Group, Inc. proceeds from issuance of long-term debt for the quarter ending 2024-09-30 was $0.00.
- LifeStance Health Group, Inc. proceeds from issuance of long-term debt for the quarter ending 2023-12-31 was $32.75M, a 65.00% increase year-over-year.
- LifeStance Health Group, Inc. proceeds from issuance of long-term debt for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- LifeStance Health Group, Inc. proceeds from issuance of long-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- LifeStance Health Group, Inc. proceeds from issuance of long-term debt for fiscal 2024 was $287.81M, a 398.34% increase from fiscal 2023.
- LifeStance Health Group, Inc. proceeds from issuance of long-term debt for fiscal 2023 was $57.75M, a 77.56% decline from fiscal 2022.
- LifeStance Health Group, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $257.32M, a 160.45% increase from fiscal 2021.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 4 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | ||||
| 2024-12-31 | $287.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $287.81M derived: sum of 2 quarters · filed 2026-02-25 | $287.81M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | ||||
| 2023-12-31 | $32.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $32.75M derived: sum of 2 quarters · filed 2026-02-25 | $57.75M derived: sum of 3 quarters · filed 2026-02-25 | $57.75M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $25.00M derived: sum of 2 quarters · filed 2024-11-07 | $25.00M 10-Q · filed 2024-11-07 | $44.85M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $25.00M 10-Q · filed 2024-08-08 | $44.85M derived: sum of 3 quarters · filed 2025-02-27 | $54.32M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $19.85M derived: sum of 2 quarters · filed 2025-02-27 | $29.32M derived: sum of 3 quarters · filed 2025-02-27 | $237.32M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $19.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $29.32M derived: sum of 2 quarters · filed 2025-02-27 | $237.32M derived: sum of 3 quarters · filed 2025-02-27 | $257.32M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $9.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $217.47M derived: sum of 2 quarters · filed 2023-11-08 | $237.47M 10-Q · filed 2023-11-08 | $237.47M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $208.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $228.00M 10-Q · filed 2023-08-09 | $228.00M derived: sum of 3 quarters · filed 2024-02-28 | $228.00M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $20.00M 10-Q · filed 2023-05-10 | $20.00M derived: sum of 2 quarters · filed 2024-02-28 | $20.00M derived: sum of 3 quarters · filed 2024-02-28 | $92.60M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $72.60M derived: sum of 3 quarters · filed 2024-02-28 | $98.80M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $72.60M derived: sum of 2 quarters · filed 2022-11-09 | $98.80M 10-Q · filed 2022-11-09 | $254.96M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-06-30 | $72.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $98.80M 10-Q · filed 2022-08-10 | $254.96M derived: sum of 3 quarters · filed 2023-03-09 | $254.96M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-03-31 | $26.20M 10-Q · filed 2022-05-11 | $182.36M derived: sum of 2 quarters · filed 2023-03-09 | $182.36M derived: sum of 3 quarters · filed 2023-03-09 | $418.26M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2020-12-31 | $156.16M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $156.16M derived: sum of 2 quarters · filed 2023-03-09 | $392.06M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-10 | $235.90M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $235.90M 10-Q · filed 2021-08-12 | ||||
| 2020-05-14 | $74.35M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $55.94M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |